| 000 | 01740 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517233135.0 | ||
| 264 | 0 | _c20181126 | |
| 008 | 201811s 0 0 eng d | ||
| 022 | _a1303-6165 | ||
| 024 | 7 |
_a10.3906/sag-1710-93 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAzarnezhad, Asaad | |
| 245 | 0 | 0 |
_aDetection of
CCND1
,
C-MYC
, and
FGFR1
amplification using modified SYBR Green
qPCR and FISH in breast cancer _h[electronic resource] |
| 260 |
_bTurkish journal of medical sciences _cAug 2018 |
||
| 300 |
_a759-767 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Validation Study | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aBenzothiazoles |
| 650 | 0 | 4 |
_aBreast Neoplasms _xgenetics |
| 650 | 0 | 4 |
_aCarcinoma, Ductal, Breast _xgenetics |
| 650 | 0 | 4 |
_aCyclin D1 _xgenetics |
| 650 | 0 | 4 |
_aDNA-Binding Proteins _xgenetics |
| 650 | 0 | 4 | _aDiamines |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Amplification |
| 650 | 0 | 4 | _aGene Dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIn Situ Hybridization, Fluorescence _xmethods |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Grading |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aOrganic Chemicals |
| 650 | 0 | 4 | _aQuinolines |
| 650 | 0 | 4 |
_aReal-Time Polymerase Chain Reaction _xmethods |
| 650 | 0 | 4 |
_aReceptor, Fibroblast Growth Factor, Type 1 _xgenetics |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 |
_aTranscription Factors _xgenetics |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aTabrizi, Mina | |
| 700 | 1 | _aJavan, Firouzeh | |
| 700 | 1 | _aMehdipour, Parvin | |
| 773 | 0 |
_tTurkish journal of medical sciences _gvol. 48 _gno. 4 _gp. 759-767 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3906/sag-1710-93 _zAvailable from publisher's website |
| 999 |
_c28741167 _d28741167 |
||